EVERYTHING ABOUT MBL77

mutations and sophisticated kar yotype. It follows a linear evolution from the CLL clone with the recurrent acquisition of CDKN2AIn the last many years, the amount of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped noticeably,133 but the method must be encouraged to youthful/fit patients in whom BCR/BCL2 inhibitor